Zago Wagner M. sold (to issuer) $437K of PRTA
Zago Wagner M. (Chief Scientific Officer) sold (to issuer) 51,000 shares of PROTHENA CORP PUBLIC LTD CO (PRTA) at $8.56 ($0.44M total) on 2026-07-28.
How this was made
The 30-second read
Why it matters
The newest fact is the specific insider sale details: 51,000 shares sold to the issuer at $8.56/share, totaling $436,560, with holdings after transaction of 34,000 shares.
Market read
Traders may note insider activity, but there is no accompanying fundamental catalyst in the text.
What to watch
Insider sales to the issuer (often buyback-related) can be administrative and may not reflect bearish fundamentals; the filing lacks any accompanying company guidance or performance update.
Background
The article is a SEC Form 4 insider transaction disclosure for Prothena Corp. Public Ltd Co (PRTA).
Ticker impact
Prothena (PRTA) disclosed an insider sale to the issuer by CSO Zago Wagner M., selling 51,000 shares at $8.56 on 2026-07-28.
Likely limited near-term impact; any effect would be sentiment-driven and typically fades unless accompanied by additional disclosures.
The filing provides transaction size, price, and post-sale holdings, but no new operational, financial, or regulatory information about PRTA.
Market effects
No clear sector read-through from a single insider sale to the issuer.
None indicated.
None indicated.
Counterpoint
The absence of a 10b5-1 plan could be interpreted as less mechanical selling, but the article does not provide motive or context.
Key entities
- issuerPROTHENA CORP PUBLIC LTD CO
Subject of the Form 4 insider transaction disclosure (PRTA).
- insiderZago Wagner M.
Chief Scientific Officer who sold shares to the issuer.